Marcelo Negrao, Assistant Professor of Medical Oncology at MD Anderson Cancer Center, shared his recent article on LinkedIn:
“Excited to see our manuscript published AACR – excellent example of team work to improve outcomes for lung patients.
Impact of co-mutations and transcriptional signatures in non-small cell lung cancer patients treated with adagrasib in the KRYSTAL-1 trial.”
Impact of co-mutations and transcriptional signatures in non-small cell lung cancer patients treated with adagrasib in the KRYSTAL-1 trial.
Authors: Marcelo V. Negrao, et al.
